Clinical Trial Update: Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update evaluating cyclosporine, pravastatin sodium, etoposide, and mitoxantrone hydrochloride in relapsed or refractory acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Etoposide (Etoposide)
• Mitoxantrone hydrochloride (mitoxantrone)
• Pravastatin Sodium (pravastatin sodium)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-07-02